aTyr Pharma | LIFE - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Ardelyx USD 246.97M 2.62M 2026-03
aTyr Pharma USD 62.99M 46.35M 2026-03
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cipla INR 807.78M 17K 2026-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1000 2026-03
CSL USD 482.13M 93.87M 2025-12
Curis USD 12.93M 12.87M 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Grifols EUR 680.58M 846.11K 2025-12
Lakefront Biotherapeutics EUR 65.9M 0 2026-03
Novartis USD 1.91B 60K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
United Therapeutics USD 42.16M 1.49M 2026-03
Xoma USD 87K 1000 2024-06